Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 3,337-3,348 of 5,650
Behavioral study icon
RecruitingNCT07045142

Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients

This study is looking at investigate how atorvastatin affects glucose metabolism in schizophrenia patients and assess whether metformin can help improve these metabolic issues. Participants receive Atorvastatin or placebo and complete study visits and assessments.

Multiple locations, including Zhumadian
SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
China
Sponsor
Central South University
Condition
Schizophrenia
Drug study icon
RecruitingNCT06877858

MethaLoad Dose-Finding Study

This summary needs review. Please check the official study record and contact the research team for details.

In Philadelphia
AddictionDrugA study involving a medication or substance.Over 18 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
Addiction
Other study type icon
RecruitingISRCTN13516283

Methodological optimization of the CO2 challenge

This observational study is following people with panic disorder, anxiety or Mental and Behavioural Disorders to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In Netherlands
AnxietyOtherFrom 18 Years to 65 Years
Countries
Netherlands
Sponsor
Centre for Human Drug Research
Condition
Anxiety
Drug study icon
RecruitingNCT05776056

Methylphenidate for PTSD With Associated Neurocognitive Complaints

This study is looking at evaluate the ability of methylphenidate to treat PTSD and associated neurocognitive complaints in Veterans for people with PTSD. Participants receive Methylphenidate or placebo and complete study visits and assessments.

Multiple locations, including Birmingham
PTSDDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
VA Office of Research and Development
Condition
PTSD
Behavioral study icon
RecruitingNCT06906328

MEthylphenidate for ADHD

This study is recruiting in France. It is testing mEthylphenidate for ADHD.

Multiple locations, including Brest
ADHD, AddictionBehavioralFrom 18 Years to 99 Years
Countries
France
Sponsor
Nantes University Hospital
Condition
ADHD, Addiction
Drug study icon
RecruitingNCT02951754

Methylphenidate in Adults With Attention Deficit/Hyperactivity Disorder

This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

In Porto Alegre
ADHDDrugOver 18 Years
Countries
Brazil
Sponsor
Hospital de Clinicas de Porto Alegre
Condition
ADHD
Drug study icon
RecruitingNCT06465641

Methylphenidate in KBG Syndrome: N-of-1 Series

This study is comparing Methylphenidate Hydrochloride with placebo for people with Kbg Syndrome or ADHD - Combined Type. Participants receive Methylphenidate Hydrochloride or placebo and complete study visits and assessments.

In Nijmegen
ADHDDrugFrom 6 Years to 20 Years
Countries
Netherlands
Sponsor
Radboud University Medical Center
Condition
ADHD
Drug study icon
RecruitingNCT07226219

Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease

This study is looking at whether Extended-Release Methylphenidate can help people with Sickle Cell Disease, Executive Dysfunction, Cognitive Impairment, or Attention Deficit/Hyperactivity Disorder. Participants receive a study treatment and complete follow-up visits and assessments.

In Memphis
ADHDDrugFrom 8 Years to 17 Years
Countries
United States
Sponsor
St. Jude Children's Research Hospital
Condition
ADHD
Drug study icon
RecruitingNCT06305182

Metreleptin in Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In Zurich
Eating disordersDrugFrom 17 Years to 65 Years
Countries
Switzerland
Sponsor
Gabriella Milos
Condition
Eating disorders
Behavioral study icon
RecruitingNCT07225179

mHealth for Early Psychosis Caregivers in Statewide Program Outreach

This study is looking at whether psychoeducation can help people with Caregiver, Caregiver Distress, Caregiver to a Young With Early Psychosis, or Family Caregivers. Participants take part in psychoeducation and complete follow-up assessments.

In Chapel Hill
SchizophreniaBehavioralOver 18 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.